Inhibitory Effect of and Isolated from the Faeces of Healthy Infants Against Nonfermentative Bacteria Causing Nosocomial Infections

Overview

Journal New Microbes New Infect

Publisher Elsevier

Specialty Infectious Diseases

Date 2016 Nov 11

PMID 27830081

Citations 11

Authors

M M Soltan Dallal

A Davoodabadi

M Abdi

M Hajiabdolbaghi

M K Sharifi Yazdi

M Douraghi

S M Tabatabaei Bafghi

Affiliations

Soon will be listed here.

Abstract

Nosocomial infection constitutes a major public health problem worldwide. Increasing antibiotic resistance of pathogens associated with nosocomial infections has also become a major therapeutic challenge for physicians. Thus, development of alternative treatment protocols, such as the use of probiotics, matters. The aim of this research was to determine the antagonistic properties of and isolated from the faeces of healthy infants against nonfermentative bacteria causing nosocomial infections. One hundred five samples of nosocomial infections were collected and processed for bacterial isolation and antimicrobial susceptibility testing following standard bacteriologic techniques. The antibiotic susceptibility test was performed by the disk diffusion method, and antagonistic effect of strains was investigated by well diffusion method. Of 105 samples, a total of 29 bacterial strains were identified as nonfermentative bacteria, including 17 and 12 . showed high resistance to tested antibiotics except ampicillin/sulbactam, and showed resistance to ampicillin/sulbactam and gentamicin and sensitive to amikacin and meropenem. had antagonistic properties against both and strains had considerable effects on preventing the growth of and strains However, further research is needed to better understanding of these effects on .

Citing Articles

Antibacterial Activity and Toxicity of Zinc Oxide Nanoparticles Combined with Supernatants of spp. Against ESKAPE Bacteria: A Novel Mixture.

Soleymanzadeh Moghadam S, Doust R, Majidpour A, Adabi M, Minaeian S Iran J Pharm Res. 2024; 22(1):e139222.

PMID: 38444715 PMC: 10912863. DOI: 10.5812/ijpr-139222.

Isolation and Identification of Effective Probiotics on Drug-Resistant Strains and Their Biofilms.

Abbasi Z, Ghasemi S, Ahmadi Y, Shokri D Can J Infect Dis Med Microbiol. 2024; 2024:8570521.

PMID: 38440403 PMC: 10911883. DOI: 10.1155/2024/8570521.

Development and Characterization of Hydroxyethyl Cellulose-Based Gels Containing Lactobacilli Strains: Evaluation of Antimicrobial Effects in In Vitro and Ex Vivo Models.

Sousa M, Ferreira A, da Silva C, Silva M, Bazan T, Monteiro C Pharmaceuticals (Basel). 2023; 16(3).

PMID: 36986568 PMC: 10058878. DOI: 10.3390/ph16030468.

Bidirectional effects of intestinal microbiota and antibiotics: a new strategy for colorectal cancer treatment and prevention.

Zhang W, Zhang J, Liu T, Xing J, Zhang H, Wang D J Cancer Res Clin Oncol. 2022; 148(9):2387-2404.

PMID: 35661254 DOI: 10.1007/s00432-022-04081-3.

The as a Probiotic: Focusing on Liver Diseases.

Jeong J, Park H, Cha M, Park E, Won S, Ganesan R Microorganisms. 2022; 10(2).

PMID: 35208742 PMC: 8879051. DOI: 10.3390/microorganisms10020288.

References

Coconnier M, Lievin V, Hemery E, Servin A . Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl Environ Microbiol. 1998; 64(11):4573-80. PMC: 106686. DOI: 10.1128/AEM.64.11.4573-4580.1998. View

Ferrara A . Potentially multidrug-resistant non-fermentative Gram-negative pathogens causing nosocomial pneumonia. Int J Antimicrob Agents. 2006; 27(3):183-95. DOI: 10.1016/j.ijantimicag.2005.11.005. View

Takahashi M, Taguchi H, Yamaguchi H, Osaki T, Komatsu A, Kamiya S . The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice. FEMS Immunol Med Microbiol. 2004; 41(3):219-26. DOI: 10.1016/j.femsim.2004.03.010. View

Kotzampassi K, Giamarellos-Bourboulis E . Probiotics for infectious diseases: more drugs, less dietary supplementation. Int J Antimicrob Agents. 2012; 40(4):288-96. DOI: 10.1016/j.ijantimicag.2012.06.006. View

Kamat U, Ferreira A, Savio R, Motghare D . Antimicrobial resistance among nosocomial isolates in a teaching hospital in goa. Indian J Community Med. 2009; 33(2):89-92. PMC: 2784633. DOI: 10.4103/0970-0218.40875. View

Servin A, Coconnier M . Adhesion of probiotic strains to the intestinal mucosa and interaction with pathogens. Best Pract Res Clin Gastroenterol. 2003; 17(5):741-54. DOI: 10.1016/s1521-6918(03)00052-0. View

Davoodabadi A, Mehdi Soltan Dallal M, Rahimi Foroushani A, Douraghi M, Sharifi Yazdi M, Amin Harati F . Antibacterial activity of Lactobacillus spp. isolated from the feces of healthy infants against enteropathogenic bacteria. Anaerobe. 2015; 34:53-8. DOI: 10.1016/j.anaerobe.2015.04.014. View

Gu R, Yang Z, Li Z, Chen S, Luo Z . Probiotic properties of lactic acid bacteria isolated from stool samples of longevous people in regions of Hotan, Xinjiang and Bama, Guangxi, China. Anaerobe. 2008; 14(6):313-7. DOI: 10.1016/j.anaerobe.2008.06.001. View

Tsai C, Lin P, Hsieh Y . Three Lactobacillus strains from healthy infant stool inhibit enterotoxigenic Escherichia coli grown in vitro. Anaerobe. 2008; 14(2):61-7. DOI: 10.1016/j.anaerobe.2007.11.003. View

10.

Valdez J, Peral M, Rachid M, Santana M, Perdigon G . Interference of Lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected burns: the potential use of probiotics in wound treatment. Clin Microbiol Infect. 2005; 11(6):472-9. DOI: 10.1111/j.1469-0691.2005.01142.x. View

11.

Servin A . Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev. 2004; 28(4):405-40. DOI: 10.1016/j.femsre.2004.01.003. View

12.

McDonnell G, Russell A . Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev. 1999; 12(1):147-79. PMC: 88911. DOI: 10.1128/CMR.12.1.147. View

13.

Jara S, Sanchez M, Vera R, Cofre J, Castro E . The inhibitory activity of Lactobacillus spp. isolated from breast milk on gastrointestinal pathogenic bacteria of nosocomial origin. Anaerobe. 2011; 17(6):474-7. DOI: 10.1016/j.anaerobe.2011.07.008. View

14.

Yun J, Lee K, Sung Y, Kim E, Lee H, Choi Y . Isolation and characterization of potential probiotic lactobacilli from pig feces. J Basic Microbiol. 2008; 49(2):220-6. DOI: 10.1002/jobm.200800119. View

15.

Karlowsky J, Draghi D, Jones M, Thornsberry C, Friedland I, Sahm D . Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001. Antimicrob Agents Chemother. 2003; 47(5):1681-8. PMC: 153334. DOI: 10.1128/AAC.47.5.1681-1688.2003. View